Thomas P. McKenna - 22 Sep 2021 Form 3 Insider Report for Thorne Healthtech, Inc.

Role
Chief Operating Officer, Director
Signature
/s/ Scott Wheeler, under power of attorney
Issuer symbol
N/A
Transactions as of
22 Sep 2021
Net transactions value
$0
Form type
3
Filing time
22 Sep 2021, 18:16:37 UTC
Next filing
28 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding THRN Class A Common Stock 145,960 22 Sep 2021 Direct F1, F2
holding THRN Class B Common Stock 84,550 22 Sep 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 89,000 $1.35 Direct F1, F4
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 178,000 $4.49 Direct F1, F4
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 186,900 $6.74 Direct F1, F4
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 639,910 $5.12 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the completion of the Issuer's initial public offering of Common Stock (the "IPO"), the Class A Common Stock shall be re-named Common Stock.
F2 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs shall vest on each one-year anniversary of the expiration of the lock-up period pertaining to the IPO, subject to the Reporting Person continuing as a service provider through each such date.
F3 Each share of Class B Common Stock shall be converted into one share of Common Stock immediately prior to the completion of the IPO.
F4 All of the shares subject to the option are fully vested and exercisable as of the date hereof.
F5 One-fourth of the shares subject to the option vested on October 10, 2019 and one-fourth of the shares subject to the option vest on each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

Exhibit 24 - Power of Attorney